<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="23">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02542280</url>
  </required_header>
  <id_info>
    <org_study_id>abahaa050301</org_study_id>
    <nct_id>NCT02542280</nct_id>
  </id_info>
  <brief_title>Does Endometrial Injury Improve Intrauterine Insemination Outcome?</brief_title>
  <official_title>Endometrial Injury May Increase the Pregnancy Rate in Patients Undergoing Intrauterine Insemination</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams Maternity Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams Maternity Hospital</source>
  <oversight_info>
    <authority>Egypt: Ministry of Higher Education</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigator suggests that local endometrial injury using pipelle catheter performed in
      the follicular phase (cycle day 5, 6 or 7) of the stimulation cycle may improve the
      pregnancy rates among patients undergoing intrauterine insemination.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a selected group of patients with repeated implantation failure, endometrial injury in
      the preceding cycle may improve ICSI outcome.

      Little is known about the efficacy of this procedure in improving intrauterine insemination
      outcome.

      Also little is known about the effect of this procedure if done in the stimulation cycle
      weather in ICSI or intrauterine insemination cycles.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Chemical Pregnancy Rate</measure>
    <time_frame>two weeks after intrauterine insemination</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Human chorionic gonadotrophin (b-hcg) detection in serum two weeks after intrauterine insemination.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Pregnancy Rate</measure>
    <time_frame>six weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Ultrasound detection of an intrauterine positive fetal heart pulsations</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">360</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>endometrial injury</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endometrial injury during ovarian stimulation combined with intrauterine insemination.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no endometrial injury</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ovarian stimulation combined with intrauterine insemination.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endometrial injury.</intervention_name>
    <description>Endometrial injury using a pipelle biopsy catheter on day (5, 6 or 7) of the stimulation cycle combined with the intrauterine insemination.</description>
    <arm_group_label>endometrial injury</arm_group_label>
    <other_name>endometrial scratch.</other_name>
    <other_name>endometrial sample.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>intrauterine insemination</intervention_name>
    <description>Placement of washed sperm in the uterus using a catheter, around the time of ovulation.</description>
    <arm_group_label>endometrial injury</arm_group_label>
    <arm_group_label>no endometrial injury</arm_group_label>
    <other_name>artificial insemination</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ovarian stimulation</intervention_name>
    <description>Inducing ovulation by human menopausal gonadotrophin ampoules given intramuscular starting from cycle day two, till the leading follicle reaches 16 - 18 mm.</description>
    <arm_group_label>endometrial injury</arm_group_label>
    <arm_group_label>no endometrial injury</arm_group_label>
    <other_name>controlled ovarian hyperstimulatiom</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 - 38 years.

          -  patent fallopian tunes.

          -  mild male factor.

          -  anovulation.

          -  unexplained infertility.

        Exclusion Criteria:

          -  indications for ICSI.

          -  evidence of pelvic inflammatory disease.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed Bahaa</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lecturer in Obstetrics and Gynecology, faculty of medicine, Ain Shams University.</affiliation>
  </overall_official>
  <verification_date>November 2015</verification_date>
  <lastchanged_date>December 3, 2015</lastchanged_date>
  <firstreceived_date>September 3, 2015</firstreceived_date>
  <firstreceived_results_date>October 2, 2015</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams Maternity Hospital</investigator_affiliation>
    <investigator_full_name>Ahmed Mohamed Bahaa Eldin Ahmed</investigator_full_name>
    <investigator_title>lesturer in Obstetrics and Gynecology.</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were recruited from the infertility clinic and given appointments to go to the Assisted Reproductive Technology unit to start the process of IUI.</recruitment_details>
      <pre_assignment_details>11 patients were excluded because they did not show up for their appointments in assisted reproductive technology unit.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Endometrial Injury</title>
          <description>Endometrial injury during ovarian stimulation cycle combined with intrauterine insemination.
endometrial injury: Endometrial injury using a pipelle biopsy catheter on day (5, 6 or 7) of the stimulation cycle combined with the intrauterine insemination.
intrauterine insemination: Placement of washed sperm in the uterus using a catheter, around the time of ovulation.
ovarian stimulation: Inducing ovulation by clomiphene citrate 100mg orally (from cycle day 2 for 5 days) and human menopausal gonadotrophin ampoules given intramuscular starting from cycle day two, till the leading follicle reaches 16 - 18 mm.</description>
        </group>
        <group group_id="P2">
          <title>no Endometrial Injury</title>
          <description>Ovarian stimulation combined with intrauterine insemination.
intrauterine insemination: Placement of washed sperm in the uterus using a catheter, around the time of ovulation.
ovarian stimulation: Inducing ovulation by clomiphene citrate 100mg orally (from cycle day 2 for 5 days) and human menopausal gonadotrophin ampoules given intramuscular starting from cycle day two, till the leading follicle reaches 16 - 18 mm.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="174"/>
                <participants group_id="P2" count="175"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="162"/>
                <participants group_id="P2" count="167"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Endometrial Injury</title>
          <description>Endometrial injury during ovarian stimulation combined with intrauterine insemination.
endometrial injury.: Endometrial injury using a pipelle biopsy catheter on day (5, 6 or 7) of the stimulation cycle combined with the intrauterine insemination.
intrauterine insemination: Placement of washed sperm in the uterus using a catheter, around the time of ovulation.
ovarian stimulation: Inducing ovulation by human menopausal gonadotrophin ampoules given intramuscular starting from cycle day two, till the leading follicle reaches 16 - 18 mm.</description>
        </group>
        <group group_id="B2">
          <title>no Endometrial Injury</title>
          <description>Ovarian stimulation combined with intrauterine insemination.
intrauterine insemination: Placement of washed sperm in the uterus using a catheter, around the time of ovulation.
ovarian stimulation: Inducing ovulation by human menopausal gonadotrophin ampoules given intramuscular starting from cycle day two, till the leading follicle reaches 16 - 18 mm.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="162"/>
                <measurement group_id="B2" value="167"/>
                <measurement group_id="B3" value="329"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="28.57" spread="3.99"/>
                <measurement group_id="B2" value="29.52" spread="4.09"/>
                <measurement group_id="B3" value="29.1" spread="4.1"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="162"/>
                <measurement group_id="B2" value="167"/>
                <measurement group_id="B3" value="329"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Egypt</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="162"/>
                <measurement group_id="B2" value="167"/>
                <measurement group_id="B3" value="329"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="28.5" spread="4"/>
                <measurement group_id="B2" value="29.35" spread="3.02"/>
                <measurement group_id="B3" value="28.9" spread="3.6"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Chemical Pregnancy Rate</title>
        <description>Human chorionic gonadotrophin (b-hcg) detection in serum two weeks after intrauterine insemination.</description>
        <time_frame>two weeks after intrauterine insemination</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Endometrial Injury</title>
            <description>Endometrial injury during ovarian stimulation combined with intrauterine insemination.
endometrial injury.: Endometrial injury using a pipelle biopsy catheter on day (5, 6 or 7) of the stimulation cycle combined with the intrauterine insemination.
intrauterine insemination: Placement of washed sperm in the uterus using a catheter, around the time of ovulation.
ovarian stimulation: Inducing ovulation by human menopausal gonadotrophin ampoules given intramuscular starting from cycle day two, till the leading follicle reaches 16 - 18 mm.</description>
          </group>
          <group group_id="O2">
            <title>no Endometrial Injury</title>
            <description>Ovarian stimulation combined with intrauterine insemination.
intrauterine insemination: Placement of washed sperm in the uterus using a catheter, around the time of ovulation.
ovarian stimulation: Inducing ovulation by human menopausal gonadotrophin ampoules given intramuscular starting from cycle day two, till the leading follicle reaches 16 - 18 mm.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="162"/>
                  <measurement group_id="O2" value="167"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Chemical Pregnancy Rate</title>
            <description>Human chorionic gonadotrophin (b-hcg) detection in serum two weeks after intrauterine insemination.</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="40"/>
                  <measurement group_id="O2" value="19"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Clinical Pregnancy Rate</title>
        <description>Ultrasound detection of an intrauterine positive fetal heart pulsations</description>
        <time_frame>six weeks</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Endometrial Injury</title>
            <description>Endometrial injury during ovarian stimulation combined with intrauterine insemination.
endometrial injury.: Endometrial injury using a pipelle biopsy catheter on day (5, 6 or 7) of the stimulation cycle combined with the intrauterine insemination.
intrauterine insemination: Placement of washed sperm in the uterus using a catheter, around the time of ovulation.
ovarian stimulation: Inducing ovulation by human menopausal gonadotrophin ampoules given intramuscular starting from cycle day two, till the leading follicle reaches 16 - 18 mm.</description>
          </group>
          <group group_id="O2">
            <title>no Endometrial Injury</title>
            <description>Ovarian stimulation combined with intrauterine insemination.
intrauterine insemination: Placement of washed sperm in the uterus using a catheter, around the time of ovulation.
ovarian stimulation: Inducing ovulation by human menopausal gonadotrophin ampoules given intramuscular starting from cycle day two, till the leading follicle reaches 16 - 18 mm.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="162"/>
                  <measurement group_id="O2" value="167"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Clinical Pregnancy Rate</title>
            <description>Ultrasound detection of an intrauterine positive fetal heart pulsations</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="32"/>
                  <measurement group_id="O2" value="13"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Endometrial Injury</title>
          <description>Endometrial injury during ovarian stimulation combined with intrauterine insemination.
endometrial injury.: Endometrial injury using a pipelle biopsy catheter on day (5, 6 or 7) of the stimulation cycle combined with the intrauterine insemination.
intrauterine insemination: Placement of washed sperm in the uterus using a catheter, around the time of ovulation.
ovarian stimulation: Inducing ovulation by human menopausal gonadotrophin ampoules given intramuscular starting from cycle day two, till the leading follicle reaches 16 - 18 mm.</description>
        </group>
        <group group_id="E2">
          <title>no Endometrial Injury</title>
          <description>Ovarian stimulation combined with intrauterine insemination.
intrauterine insemination: Placement of washed sperm in the uterus using a catheter, around the time of ovulation.
ovarian stimulation: Inducing ovulation by human menopausal gonadotrophin ampoules given intramuscular starting from cycle day two, till the leading follicle reaches 16 - 18 mm.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="162"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="162"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="167"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ahmed Bahaa</name_or_title>
      <organization>Ain Shams Maternity Hospital</organization>
      <phone>+20 1111700556</phone>
      <email>abahaa0503@yahoo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
